OSUR Stock: Price, Forecast, Financials & AI Analysis

High

Open

VWAP

Vol

Mkt Cap

Low

Amount

EV/EBITDA(TTM)

Total Shares

EV/OCF(TTM)

P/S(TTM)

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2025Q4

FY2026Q1

FY2026Q2

26.44M

-29.38%

-0.205

+46.43%

28.60M

-4.45%

-0.200

-4.76%

30.80M

-1.43%

-0.185

-28.85%

Estimates Revision

The market is revising Downward the revenue expectations for OraSure Technologies, Inc. (OSUR) for FY2025, with the revenue forecasts being adjusted by -5.58% over the past three months. During the same period, the stock price has changed by -15.71%.

Revenue Estimates for FY2025

Revise Downward

-5.58%

In Past 3 Month

EPS Estimates for FY2025

Revise Upward

+1.76%

In Past 3 Month

Stock Price

Go Down

-15.71%

In Past 3 Month

Valuation Metrics

The current forward P/E ratio for OraSure Technologies Inc (OSUR.O) is -3.05, compared to its 5-year average forward P/E of -19.34. For a more detailed relative valuation and DCF analysis to assess OraSure Technologies Inc 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

-19.34

Current PE

-3.05

Overvalued PE

36.38

Undervalued PE

-75.05

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A

5Y Average EV/EBITDA

-21.99

Current EV/EBITDA

0.84

Overvalued EV/EBITDA

182.42

Undervalued EV/EBITDA

-226.39

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

5Y Average PS

1.97

Current PS

1.48

Overvalued PS

2.67

Undervalued PS

1.28

Financials

Annual

Quarterly

N/A

Total Revenue

N/A

Operating Profit

N/A

Net Income after Tax

N/A

EPS - Diluted

N/A

Free Cash Flow

N/A

Gross Profit Margin - %

N/A

FCF Margin - %

N/A

Net Margin - %

N/A

ROIC

Trading Trends

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Hedge Fund

Hedge Funds areSelling! The selling amount has increased 2277.4% over the last quarter.

Sold

Bought

Congress Trading

Congress are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

OSUR News & Events

Events Timeline

No data

News

9.0

01-05Globenewswire

OraSure Submits FDA Applications for Rapid Self-Test Devices with $1.5B Market Potential

3.5

01-05Newsfilter

OraSure Submits Two FDA Applications, Addressable Market Exceeds $1.5 Billion

9.0

2025-12-17Globenewswire

OraSure Confirms Altai Capital's Nomination of Board Candidates

People Also Watch

Frequently Asked Questions

What is OraSure Technologies Inc (OSUR) stock price today?

The current price of OSUR is 2.63 USD — it has decreased -1.13 % in the last trading day.

What is OraSure Technologies Inc (OSUR)'s business?

OraSure Technologies, Inc. transforms health through actionable insight and decentralizes diagnostics to connect people to healthcare wherever they are. The Company improves the access, quality, and value of healthcare with innovation in effortless tests and sample management solutions. The Company, together with its wholly owned subsidiaries, DNA Genotek Inc. and Sherlock Biosciences, Inc., is engaged in the development, manufacture, and distribution of rapid diagnostic tests and sample collection and stabilization devices designed to discover and detect critical medical conditions. Its portfolio of products is sold globally to clinical laboratories, hospitals, physician’s offices, clinics, public health and community-based organizations, research institutions, government agencies, pharmaceutical companies, and direct consumers. Its products and services include OraQuick ADVANCE Rapid HIV1/2 Antibody Test, OraQuick HIV Self-Test, and Diagnostics Direct Syphilis Health Check.

What is the price predicton of OSUR Stock?

Wall Street analysts forecast OSUR stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for OSUR is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is OraSure Technologies Inc (OSUR)'s revenue for the last quarter?

OraSure Technologies Inc revenue for the last quarter amounts to 27.09M USD, decreased -32.14 % YoY.

What is OraSure Technologies Inc (OSUR)'s earnings per share (EPS) for the last quarter?

OraSure Technologies Inc. EPS for the last quarter amounts to -0.19 USD, increased 216.67 % YoY.

What changes have occurred in the market's expectations for OraSure Technologies Inc (OSUR)'s fundamentals?

How many employees does OraSure Technologies Inc (OSUR). have?

OraSure Technologies Inc (OSUR) has 501 emplpoyees as of January 10 2026.

What is OraSure Technologies Inc (OSUR) market cap?

Today OSUR has the market capitalization of 188.66M USD.